1 Market Overview
1.1 Animal-derived Immune Globulin Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal-derived Immune Globulin Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal-derived Immune Globulin Products Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Animal-derived Immune Globulin Products Market Size & Forecast
1.4.1 Global Animal-derived Immune Globulin Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Animal-derived Immune Globulin Products Sales in Volume (2017-2028)
1.4.3 Global Animal-derived Immune Globulin Products Price (2017-2028)
1.5 Global Animal-derived Immune Globulin Products Production Capacity Analysis
1.5.1 Global Animal-derived Immune Globulin Products Total Production Capacity (2017-2028)
1.5.2 Global Animal-derived Immune Globulin Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal-derived Immune Globulin Products Market Drivers
1.6.2 Animal-derived Immune Globulin Products Market Restraints
1.6.3 Animal-derived Immune Globulin Products Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Animal-derived Immune Globulin Products Product and Services
2.1.4 Pfizer Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Rare Disease Therapeutics
2.2.1 Rare Disease Therapeutics Details
2.2.2 Rare Disease Therapeutics Major Business
2.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product and Services
2.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Instituto Bioclon
2.3.1 Instituto Bioclon Details
2.3.2 Instituto Bioclon Major Business
2.3.3 Instituto Bioclon Animal-derived Immune Globulin Products Product and Services
2.3.4 Instituto Bioclon Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck & Co
2.4.1 Merck & Co Details
2.4.2 Merck & Co Major Business
2.4.3 Merck & Co Animal-derived Immune Globulin Products Product and Services
2.4.4 Merck & Co Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Animal-derived Immune Globulin Products Product and Services
2.5.4 Sanofi Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Protherics
2.6.1 Protherics Details
2.6.2 Protherics Major Business
2.6.3 Protherics Animal-derived Immune Globulin Products Product and Services
2.6.4 Protherics Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Genzyme Corporation
2.7.1 Genzyme Corporation Details
2.7.2 Genzyme Corporation Major Business
2.7.3 Genzyme Corporation Animal-derived Immune Globulin Products Product and Services
2.7.4 Genzyme Corporation Animal-derived Immune Globulin Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Animal-derived Immune Globulin Products Breakdown Data by Manufacturer
3.1 Global Animal-derived Immune Globulin Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Animal-derived Immune Globulin Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Animal-derived Immune Globulin Products
3.4 Market Concentration Rate
3.4.1 Top 3 Animal-derived Immune Globulin Products Manufacturer Market Share in 2021
3.4.2 Top 6 Animal-derived Immune Globulin Products Manufacturer Market Share in 2021
3.5 Global Animal-derived Immune Globulin Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Animal-derived Immune Globulin Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Animal-derived Immune Globulin Products Market Size by Region
4.1.1 Global Animal-derived Immune Globulin Products Sales in Volume by Region (2017-2028)
4.1.2 Global Animal-derived Immune Globulin Products Revenue by Region (2017-2028)
4.2 North America Animal-derived Immune Globulin Products Revenue (2017-2028)
4.3 Europe Animal-derived Immune Globulin Products Revenue (2017-2028)
4.4 Asia-Pacific Animal-derived Immune Globulin Products Revenue (2017-2028)
4.5 South America Animal-derived Immune Globulin Products Revenue (2017-2028)
4.6 Middle East and Africa Animal-derived Immune Globulin Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Animal-derived Immune Globulin Products Sales in Volume by Type (2017-2028)
5.2 Global Animal-derived Immune Globulin Products Revenue by Type (2017-2028)
5.3 Global Animal-derived Immune Globulin Products Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Animal-derived Immune Globulin Products Sales in Volume by Application (2017-2028)
6.2 Global Animal-derived Immune Globulin Products Revenue by Application (2017-2028)
6.3 Global Animal-derived Immune Globulin Products Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Animal-derived Immune Globulin Products Sales by Type (2017-2028)
7.2 North America Animal-derived Immune Globulin Products Sales by Application (2017-2028)
7.3 North America Animal-derived Immune Globulin Products Market Size by Country
7.3.1 North America Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
7.3.2 North America Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Animal-derived Immune Globulin Products Sales by Type (2017-2028)
8.2 Europe Animal-derived Immune Globulin Products Sales by Application (2017-2028)
8.3 Europe Animal-derived Immune Globulin Products Market Size by Country
8.3.1 Europe Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
8.3.2 Europe Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2017-2028)
9.2 Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2017-2028)
9.3 Asia-Pacific Animal-derived Immune Globulin Products Market Size by Region
9.3.1 Asia-Pacific Animal-derived Immune Globulin Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Animal-derived Immune Globulin Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Animal-derived Immune Globulin Products Sales by Type (2017-2028)
10.2 South America Animal-derived Immune Globulin Products Sales by Application (2017-2028)
10.3 South America Animal-derived Immune Globulin Products Market Size by Country
10.3.1 South America Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
10.3.2 South America Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal-derived Immune Globulin Products Sales by Type (2017-2028)
11.2 Middle East & Africa Animal-derived Immune Globulin Products Sales by Application (2017-2028)
11.3 Middle East & Africa Animal-derived Immune Globulin Products Market Size by Country
11.3.1 Middle East & Africa Animal-derived Immune Globulin Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Animal-derived Immune Globulin Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Animal-derived Immune Globulin Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of Animal-derived Immune Globulin Products
12.3 Animal-derived Immune Globulin Products Production Process
12.4 Animal-derived Immune Globulin Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Animal-derived Immune Globulin Products Typical Distributors
13.3 Animal-derived Immune Globulin Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の動物由来免疫グロブリン製品市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global Animal-derived Immune Globulin Products Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3744 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：98 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 動物由来免疫グロブリン製品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の動物由来免疫グロブリン製品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 動物由来免疫グロブリン製品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・IVIg液体、IVIgパウダー 用途別セグメントは次のように区分されます。 ・免疫不全、自己免疫疾患、急性感染症 世界の動物由来免疫グロブリン製品市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、Rare Disease Therapeutics、Instituto Bioclon、Merck & Co、Sanofi、Protherics、Genzyme Corporation 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、動物由来免疫グロブリン製品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な動物由来免疫グロブリン製品メーカーの企業概要、2019年～2022年までの動物由来免疫グロブリン製品の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な動物由来免疫グロブリン製品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別動物由来免疫グロブリン製品の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの動物由来免疫グロブリン製品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での動物由来免疫グロブリン製品市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および動物由来免疫グロブリン製品の産業チェーンを掲載しています。 ・第13、14、15章では、動物由来免疫グロブリン製品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 動物由来免疫グロブリン製品の概要 - 種類別分析（2017年vs2021年vs2028年）：IVIg液体、IVIgパウダー - 用途別分析（2017年vs2021年vs2028年）：免疫不全、自己免疫疾患、急性感染症 - 世界の動物由来免疫グロブリン製品市場規模・予測 - 世界の動物由来免疫グロブリン製品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Rare Disease Therapeutics、Instituto Bioclon、Merck & Co、Sanofi、Protherics、Genzyme Corporation ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：IVIg液体、IVIgパウダー ・用途別分析2017年-2028年：免疫不全、自己免疫疾患、急性感染症 ・動物由来免疫グロブリン製品の北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・動物由来免疫グロブリン製品のヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・動物由来免疫グロブリン製品のアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・動物由来免疫グロブリン製品の南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・動物由来免疫グロブリン製品の中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Animal-derived Immune Globulin Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Animal-derived Immune Globulin Products market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunodeficiency accounting for % of the Animal-derived Immune Globulin Products global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While IVIg Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Animal-derived Immune Globulin Products include Pfizer, Rare Disease Therapeutics, Instituto Bioclon, Merck & Co, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Animal-derived Immune Globulin Products market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IVIg Liquid
IVIg Powder
Market segment by Application can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
The key market players for global Animal-derived Immune Globulin Products market are listed below:
Pfizer
Rare Disease Therapeutics
Instituto Bioclon
Merck & Co
Sanofi
Protherics
Genzyme Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal-derived Immune Globulin Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Animal-derived Immune Globulin Products, with price, sales, revenue and global market share of Animal-derived Immune Globulin Products from 2019 to 2022.
Chapter 3, the Animal-derived Immune Globulin Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal-derived Immune Globulin Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Animal-derived Immune Globulin Products market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Animal-derived Immune Globulin Products.
Chapter 13, 14, and 15, to describe Animal-derived Immune Globulin Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の動物由来免疫グロブリン製品市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3744)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の動物由来免疫グロブリン製品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
